Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R G Pendleton

Showing results (61-70 of 69) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 69 results.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1979
Studies on SK&F 29661, an organ-specific inhibitor of phenylethanolamine N-methyltransferaseR G Pendleton, G Gessner, G Weiner, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1972
Effect of propranolol upon the hemoglobin-oxygen dissociation curveR G Pendleton, D J Newman, S S Sherman, et al.
Clinical Pharmacology and Therapeutics|June 1, 1979
Studies with a PNMT inhibitorJ W Dubb, R M Stote, F Alexander, et al.
Journal of Medicinal Chemistry|July 1, 1989
Tetrahydrothiadiazoloisoquinolines: synthesis and inhibition of phenylethanolamine-N-methyltransferaseG R Girard, W E Bondinell, L M Hillegass, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1987
Roles of endogenous cholecystokinin in biliary, pancreatic and gastric function: studies with L-364,718, a specific cholecystokinin receptor antagonistR G Pendleton, R J Bendesky, L Schaffer, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1987
In vivo pharmacology of L-364,718, a new potent nonpeptide peripheral cholecystokinin antagonistV J Lotti, R G Pendleton, R J Gould, et al.
Journal of Cardiovascular Pharmacology|September 1, 1983
Cardiovascular activity of SK&F 64139 in the hypertensive ratJ P Hieble, J P McCafferty, J M Roesler, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1990
RG 12915: a potent 5-hydroxytryptamine-3 antagonist that is an orally effective inhibitor of cytotoxic drug-induced emesis in the ferret and dogL R Fitzpatrick, R M Lambert, C E Pendley, et al.
Journal of Medicinal Chemistry|May 1, 1980
Inhibitors of phenylethanolamine N-methyltransferase and epinephrine biosynthesis. 1. Chloro-substituted 1,2,3,4-tetrahydroisoquinolinesW E Bondinell, F W Chapin, G R Girard, et al.
Pageof 7

Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
The Journal of Pharmacology and Experimental Therapeutics|January 1, 1979
Studies on SK&F 29661, an organ-specific inhibitor of phenylethanolamine N-methyltransferaseR G Pendleton, G Gessner, G Weiner, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1972
Effect of propranolol upon the hemoglobin-oxygen dissociation curveR G Pendleton, D J Newman, S S Sherman, et al.
Clinical Pharmacology and Therapeutics|June 1, 1979
Studies with a PNMT inhibitorJ W Dubb, R M Stote, F Alexander, et al.
Journal of Medicinal Chemistry|July 1, 1989
Tetrahydrothiadiazoloisoquinolines: synthesis and inhibition of phenylethanolamine-N-methyltransferaseG R Girard, W E Bondinell, L M Hillegass, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1987
Roles of endogenous cholecystokinin in biliary, pancreatic and gastric function: studies with L-364,718, a specific cholecystokinin receptor antagonistR G Pendleton, R J Bendesky, L Schaffer, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1987
In vivo pharmacology of L-364,718, a new potent nonpeptide peripheral cholecystokinin antagonistV J Lotti, R G Pendleton, R J Gould, et al.
Journal of Cardiovascular Pharmacology|September 1, 1983
Cardiovascular activity of SK&F 64139 in the hypertensive ratJ P Hieble, J P McCafferty, J M Roesler, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 1, 1990
RG 12915: a potent 5-hydroxytryptamine-3 antagonist that is an orally effective inhibitor of cytotoxic drug-induced emesis in the ferret and dogL R Fitzpatrick, R M Lambert, C E Pendley, et al.
Journal of Medicinal Chemistry|May 1, 1980
Inhibitors of phenylethanolamine N-methyltransferase and epinephrine biosynthesis. 1. Chloro-substituted 1,2,3,4-tetrahydroisoquinolinesW E Bondinell, F W Chapin, G R Girard, et al.
Pageof 7